Your Search for Apthous Ulcers matched 18 Documents (Page 1 of 1).
Results Indexed by relevance.

1. Thalidomide: An alternative therapy for treatment of Apthous Ulcers (Canker sores) (100%)
Abstract: Thalidomide: An alternative therapy for treatment of Apthous Ulcers (Canker sores). Seattle Treatment Education Project (STEP) Perspective, Vol. 7, No. 1 - Spring 1995; A Publication of the Seattle Treat- ment Education Project, 127 Broadway E. Ste. 200, Seattle, WA 98102 * (206) 329-4857. Published 3 times ...
http://www.aegis.com/pubs/step/1995/step7108.html
File Name: step7108.html, Size: 15KB, Last Modified: Sunday, April 30, 1995 at 11:00:00 PM

2. AEGiS OI: Apthous Ulcers (60%)
Abstract: Aphthous ulcers are painful blisters on the tongue, mouth, or genitals. ...
http://www.aegis.com/topics/oi/oi-ulcer.html
File Name: oi-ulcer.html, Size: 4KB, Last Modified: Monday, January 12, 2009 at 9:53:40 PM

3. AEGiS-CATIE: Thalidomide for ulcers -- short term use only? (60%)
Abstract: Background and Summary ...
http://www.aegis.com/pubs/catie/1997/cate8003.html
File Name: cate8003.html, Size: 9KB, Last Modified: Tuesday, March 06, 2007 at 6:43:28 PM

4. (ATDN) Thalidomide (60%)
Abstract: Thalidomide is in clinical trials now for the treatment of HIV infection, mouth ulcers, and wasting associated with HIV infecti ...
http://www.aegis.com/pubs/atdn/1995/atr01714.html
File Name: atr01714.html, Size: 4KB, Last Modified: Saturday, April 01, 1995 at 10:00:00 PM

5. Ask the Doc (45%)
Abstract: I recently went to the doctor with a very painful ulcer on the side on my tongue and my throat was very sore as well. The doctor that I saw was not an Infectious Disease doctor and I told him that I was HIV+ with a CD4 of 206. ...does Thalidomide help with Apthous Ulcers? ...
http://www.aegis.com/pubs/c/askd050220.html
File Name: askd050220.html, Size: 8KB, Last Modified: Tuesday, March 06, 2007 at 7:15:30 PM

6. Opportunistic Infections -- AIDS - HIV - ĘGIS (30%)
Abstract: Opportunistic Infections. HIV doesn't kill anybody directly. Instead, it weakens the body's ability to fight disease. Infections which are rarely seen in those with with normal immune systems are deadly to those with HIV.People with HIV can get many infections (called opportunistic infections, o ...
http://www.aegis.com/topics/oi/index.html
File Name: index.html, Size: 6KB, Last Modified: Monday, January 12, 2009 at 9:53:37 PM

7. A pilot randomized comparative study of stavudine (d4T) - didanosine (ddI)+ nevirapine (NVP) with or without hydroxyurea (HU) in primary HIV infection (PHI). (30%)
Abstract: Objective: To assess tolerability and short term virological and immunological effects of d4T +ddI+NVP with or without HU in patients (pts) with PHI. Study Design: Pilot, randomized, comparative, 48 week trial. Eligible pts had HIV exposure and (1) ELI ...
http://www.aegis.com/aidsline/2000/jun/a0060660.html
File Name: a0060660.html, Size: 10KB, Last Modified: Wednesday, June 28, 2000 at 8:12:04 PM

8. A prospective trial of thalidomide for the treatment of HIV-associated idiopathic esophageal ulcers. (30%)
Abstract: Thalidomide appears to be highly effective for oropharyngeal apthous ulcers in HIV-infected patients. However, there are limited data regarding the use of this drug for the treatment of HIV-associated idiopathic esophageal ulcer(s) (IEU). Twelve HIV-infected patients with esophageal symptoms and IEU as defined by prev ...
http://www.aegis.com/news/ine/1997/sep/m9790892.html
File Name: m9790892.html, Size: 9KB, Last Modified: Sunday, September 28, 1997 at 8:12:04 PM

9. Oral health for people with HIV infection. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply. (30%)
Abstract: Poor oral health can complicate the treatment of HIV-positive patients, exacerbating nutritional problems and making medical care more difficult. Early detection and treatment of dental and oral conditions can prevent pain and prevent opportunistic infections. HIV-positive people are susceptible to apthous ulcers, can ...
http://www.aegis.com/conferences/7/apr/m9740188.html
File Name: m9740188.html, Size: 8KB, Last Modified: Monday, April 28, 1997 at 8:12:04 PM

10. Thalidomide associated weight gain in HIV-1 (+) clients. (30%)
Abstract: Objective: To evaluate the usefulness of the tumor necrosis factor-alpha inhibitor thalidomide for weight gain in HIV-1 (+) clients buying the drug at a community based organization. Methods: Since August 15, 1995, 205 HIV-1 (+) clients were surveyed monthly by mail about demographics, medical history, current symptom ...
http://www.aegis.com/aidsline/1997/jan/m9714823.html
File Name: m9714823.html, Size: 9KB, Last Modified: Tuesday, January 28, 1997 at 8:12:04 PM

11. Thalidomide associated weight gain in HIV-1 (+) clients. (30%)
Abstract: Objective: To evaluate the usefulness of the tumor necrosis factor-alpha inhibitor thalidomide for weight gain in HIV-1 (+) clients buying the drug at a community based organization. Methods: Since August 15, 1995, 205 HIV-1 (+) clients were surveyed monthly by mail about demographics, medical history, current symptom ...
http://www.aegis.com/aidsline/1997/jan/m9713829.html
File Name: m9713829.html, Size: 9KB, Last Modified: Tuesday, January 28, 1997 at 8:12:04 PM

12. AEGiS-11IAC: Thalidomide associated weight gain in HIV-1 (+) clients. (30%)
Abstract: To evaluate the usefulness of the tumor necrosis factor-alpha inhibitor thalidomide for weight gain in HIV-1 (+) clients buying the drug at a community based organization. <p><b>METHODS</b>: Since August 15, 1995, 205 HIV-1 (+) clients were surveyed monthly by mail about demographics, medical history, current symptom ...
http://www.aegis.com/conferences/iac/1996/web180.html
File Name: web180.html, Size: 6KB, Last Modified: Sunday, July 07, 1996 at 8:12:04 PM

13. AEGiS-11IAC: Thalidomide associated weight gain in HIV-1 (+) clients. (30%)
Abstract: To evaluate the usefulness of the tumor necrosis factor-alpha inhibitor thalidomide for weight gain in HIV-1 (+) clients buying the drug at a community based organization. <p><b>METHODS</b>: Since August 15, 1995, 205 HIV-1 (+) clients were surveyed monthly by mail about demographics, medical history, current symptom ...
http://www.aegis.com/conferences/iac/1996/tub2386.html
File Name: tub2386.html, Size: 6KB, Last Modified: Sunday, July 07, 1996 at 8:12:04 PM

14. Thalidomide: an alternative therapy for treatment of apthous ulcers (canker sores). Clearinghouse, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5023. (30%)
Abstract: Thalidomide has been reported to be an effective therapy for painful oral (mouth) ulcerations associated with AIDS that do not respond to the usual treatment options available. Thalidomide was first developed and marketed in Germany in the 1950s as a sedative. It was withdrawn in ...
http://www.aegis.com/conferences/5/dec/m95c3138.html
File Name: m95c3138.html, Size: 9KB, Last Modified: Thursday, December 28, 1995 at 8:12:04 PM

15. Canadian study of ddC for advanced HIV-1 infection in patients intolerant to ZDV. (30%)
Abstract: OBJECTIVES: To study the safety of dideoxycytidine ( ddC ) in patients with advanced HIV-1 infection intolerant to zidovudine ZDV). METHODS: Patients intolerant to ZDV were enrolled in a trial of ddC safety from Nov, 1990 to Oct, 1992. RESULTS: As of De ...
http://www.aegis.com/news/ine/1993/nov/m93b3733.html
File Name: m93b3733.html, Size: 9KB, Last Modified: Sunday, November 28, 1993 at 8:12:04 PM

16. AEGiS-09IAC: Canadian study of ddC for advanced HIV-1 infection in patients intolerant to ZDV. (30%)
Abstract: <p><b>OBJECTIVES</b>: To study the safety of dideoxycytidine ( ddC ) in patients with advanced HIV-1 infection intolerant to zidovudine (ZDV). <p><b>METHODS</b>: Patients intolerant to ZDV were enrolled in a trial of ddC safety from Nov, 1990 to Oct, 1992. ...
http://www.aegis.com/conferences/iac/1993/pob262079.html
File Name: pob262079.html, Size: 6KB, Last Modified: Sunday, June 06, 1993 at 8:12:04 PM

17. AEGiS-GMHC: X-Factors - Nov / Dec 2000 (7%)
Abstract: Compounds become useful drugs only if their beneficial qualities far outweigh any harmful or unwanted activity. But drugs can have subtle, unintended effects — both good and bad — that may remain unnoticed until after they are in widespread use. ...
http://www.aegis.com/pubs/gmhc/2000/gm141103.html
File Name: gm141103.html, Size: 17KB, Last Modified: Thursday, February 05, 2004 at 2:44:13 AM

18. AEGiS-MMWR: Transmission of Primary and Secondary Syphilis by Oral Sex --- Chicago, Illinois, 1998--2002 (6%)
Abstract: During 1998--2002, the STD/HIV Prevention and Care Program of the Chicago Department of Public Health (CDPH) recorded 1,582 cases of primary and secondary (P&S) syphilis, the most of any U.S. city (1). Although case numbers and overall rates remained stable in Chicago during this period, patterns of transmission change ...
http://www.aegis.com/pubs/mmwr/2004/mm5341-966-968.html
File Name: mm5341-966-968.html, Size: 18KB, Last Modified: Thursday, October 21, 2004 at 5:54:44 PM

 
1
 
AEGiS Search Engine. Status: The Index is up to date.